Prognostic implication of dynamic platelet count in lung cancer patients with thrombocytosis: a retrospective analysis
PeerJ · 2025
DOI: 10.7717/peerj.19551 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Xiaoying Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, C…. Hauptthemen laut MEDLINE: Thrombocytosis, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changzhou Sci&Tech Program.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Thrombocytosis is associated with poor prognosis in lung cancer patients. However, no studies have further assessed the effect of platelet-related parameters on the prognosis among lung cancer patients with thrombocytosis.
Methods
Between 2020 and 2021, lung cancer patients with a platelet count ≥ 300 *10 9 /L or normal count were retrospectively reviewed. Potential prognostic factors were identified using univariate and multivariate accelerate failure time (AFT) model. Kaplan–Meier method and log-rank test were used to compare survival outcome.
Results
Among patients with thrombocytosis ( N = 148), time point of platelet elevation, platelet distribution width (PDW), platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) did not significantly impact first-line progression-free survival (PFS). Compared to patients whose platelet count normalized after treatment, patients with sustained platelet elevation exhibited a worst PFS (β = − 1.291, p < 0.001), and although patients with fluctuant platelet elevation had worse PFS (β = − 0.358, p = 0.054), the difference was not statistically significant. Additionally, mean platelet volume (MPV) (β = 0.319, p = 0.008) and D-dimer (β = − 0.046, p = 0.025) were also factors affecting first-line PFS.
Conclusions
Among platelet-related parameters, besides MPV and D-dimer, the dynamic pattern of platelet count serves as a prognostic marker in lung cancer patients with thrombocytosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, China.
Förderung
- Changzhou Sci&Tech Program
Zitieren
APA
Wang, X., Pu, X., Wu, X., Wei, Y., Wei, F., Wu, F., & Jiang, H. (2025). Prognostic implication of dynamic platelet count in lung cancer patients with thrombocytosis: a retrospective analysis. PeerJ. https://doi.org/10.7717/peerj.19551
Vancouver
Wang X, Pu X, Wu X, Wei Y, Wei F, Wu F, et al. Prognostic implication of dynamic platelet count in lung cancer patients with thrombocytosis: a retrospective analysis. PeerJ. 2025. doi:10.7717/peerj.19551
BibTeX
@article{Wang2025,
author = {Wang, Xiaoying and Pu, Xiaolin and Wu, Xinyu and Wei, Yanshuang and Wei, Feifei and Wu, Fangfang and Jiang, Hua},
title = {Prognostic implication of dynamic platelet count in lung cancer patients with thrombocytosis: a retrospective analysis},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.19551}
}
EUVIMED